ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1334 • ACR Convergence 2022

    Exploring Canadian Patient Experiences of Living with Lupus Nephritis (LN)

    Francesca S Cardwell1, Sydney George2, Adrian Boucher2, Megan R W Barber3, Kim Cheema4, Susan J Elliott5 and Ann E Clarke3, 1University of Waterloo, Department of Geography & Environmental Management, Burlington, ON, Canada, 2GlaxoSmithKline, Health Outcomes and Economics, Mississauga, ON, Canada, 3University of Calgary, Division of Rheumatology, Cumming School of Medicine, Calgary, AB, Canada, 4University of Calgary, Division of Nephrology, Cumming School of Medicine, Calgary, AB, Canada, 5University of Waterloo, Department of Geography & Environmental Management, Waterloo, ON, Canada

    Background/Purpose: LN is one of the most severe manifestations of SLE; however, the patient experience remains understudied. This research investigates patient experiences and perspectives of…
  • Abstract Number: 1328 • ACR Convergence 2022

    CT Evaluation of Bone Fragility 2 Years After Bariatric Surgery in Patients with Obesity: An Observational Study

    Marine FAUNY1, Marion Halin2, Edem Allado2, Didier Quilliot2, Laurent Brunaud2, Eliane Albuisson2, Isabelle Chary-Valckenaere2 and Damien Loeuille2, 1Nancy University Hospital, Toul, France, 2Nancy University Hospital, Vandoeuvre, France

    Background/Purpose: The objectives were to evaluate bone fragility on computed tomography (CT) in patients with obesity before and 2 years after bariatric surgery and to…
  • Abstract Number: 1340 • ACR Convergence 2022

    Nutrition-Related Behaviors and Beliefs – A Survey of Rheumatic Disease Patients

    Sandy Lee1, Leanna Wise2 and Stavros Savvas3, 1University of Southern California, Walnut, CA, 2LAC+USC/Keck Medicine of USC, Pasadena, CA, 3Keck Medicine of USC, Glendale, CA

    Background/Purpose: Diet and nutrition have long been of interest to both patients and providers in the treatment of chronic disease. The literature is relatively sparse…
  • Abstract Number: 1341 • ACR Convergence 2022

    Clinical Outcomes of COVID-19 Vaccination and Booster in Patients with Autoimmune Inflammatory Rheumatic Diseases

    Silera Holguin Balbuena, Anna Radisic, Sarah Goodman, Shreya Gor, Beatrice Wood, Alexander Shahin, Kelara Samuel, Rahul Mhaskar and John Carter, University of South Florida, Tampa, FL

    Background/Purpose: The spread of COVID-19 began in December 2019 and quickly escalated into a global pandemic resulting in millions of deaths. Many factors are associated…
  • Abstract Number: 1331 • ACR Convergence 2022

    Risk Factors for Osteoporotic Fracture in Women with Established Long-Term Rheumatoid Arthritis

    Felipe Freire da Silva1, Gisela Machado2, ana Medeiros3, Karina Bonfiglioli4, Andrea Shimabuco2, Liliam Takayama5, Rosa Pereira6 and Diogo Domiciano7, 1FMUSP, Salvador, Brazil, 2FMUSP, São Paulo, Brazil, 3Faculdade de Medicina da Universidade de São Paulo, São Jose Dos Campos, Brazil, 4Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 5University of São Paulo, São Paulo, Brazil, 6Bone Metabolism Laboratory, Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 7Hospital das Clinicas, Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Low bone mineral density (BMD) is a predictor of osteoporotic fracture. However, individuals with Rheumatoid Arthritis (RA) who sustain "osteoporosis-related" fractures frequently have normal…
  • Abstract Number: 1339 • ACR Convergence 2022

    Impact of the COVID-19 Pandemic on Patients with Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative (OBRI)

    Matthew Wong-Pack1, Elliot Hepworth2, Mohammad Movahedi3, Bindee Kuriya1, Janet Pope4, Edward Keystone5, Carter Thorne6, VANDANA AHLUWALIA7, Angela Cesta8, Carol Mously8, Claire Bombardier1, Arthur Lau9 and Sibel Aydin10, 1University of Toronto, Toronto, ON, Canada, 2University of Ottawa, Ottawa, ON, Canada, 3Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada, 4University of Western Ontario, London, ON, Canada, 5Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 6Southlake Regional Health Centre, Newmarket, ON, Canada, 7William Osler Health System, Brampton, ON, Canada, 8University Health Network, Toronto, ON, Canada, 9McMaster University, Hamilton, ON, Canada, 10University of Ottawa, Rheumatology, Ottawa, Canada, Ottawa, ON, Canada

    Background/Purpose: The COVID-19 Pandemic created challenges for patients with rheumatoid arthritis (RA), including accessing the health care system, transition to unplanned virtual care, reduction in…
  • Abstract Number: 1352 • ACR Convergence 2022

    Improving Completion Rates of Routine Mental Health Screening for Depression and Anxiety in Paediatric Lupus Outpatient Clinic to Enhance Patient Mental Health Care

    Tala El Tal1, Avery Longmore2, Abdulaziz el Mutairi1, Amani Al Bijadi1, Audrea Chen1, Holly Convery1, Dinah Finkelstein3, Linda Hiraki4, Chetana Kulkarni5, Justine Ledochowski6, Neely Lerman1, Karen Leslie7, Deborah Levy8, Sharon Lorber9, Jayne MacMahon10, Jeanine McColl11, Sarah Mossad12, Oscar Mwizerwa10, Lawrence Ng12, Luana Flores Pereira12, Vandana Rawal7, Alaa Shehab1, Evelyn Smith13, Alene Toulany14 and Andrea Knight1, 1The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 2The Hospital for Sick Children, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 3The Hospital for Sick Children, Department of Paediatrics, University of Toronto, ON, Canada, Toronto, ON, Canada, 4The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Genetics and Genome Biology, SickKids Research Institute, Toronto, ON, Canada, 5The Hospital for Sick Children, Division of Child & Youth Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada, 6The Hospital for Sick Children, Department of Psychology, University of Toronto, Toronto, ON, Canada, 7The Hospital for Sick Children, Division of Adolescent Medicine, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 8Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 9The Hospital for Sick Children, Factor Inwentash Faculty of Social Work, University of Toronto, Toronto, ON, Canada, 10The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, Toronto, ON, Canada, 11University of Toronto, Toronto, ON, Canada, 12The Hospital for Sick Children, Toronto, ON, Canada, 13The Hospital for Sick Children, Division of Psychiatry, Department of Paediatrics, University of Toronto,, Toronto, ON, Canada, 14The Hospital for Sick Children, Division of Adolescent Medicine, Department of Paediatrics, University of Toronto,, Toronto, ON, Canada

    Background/Purpose: Mental health (MH) problems are prevalent in adolescents with childhood-onset lupus (cSLE), with cross-sectional studies estimating prevalences of 20-60% for depression symptoms and 20-40%…
  • Abstract Number: 1346 • ACR Convergence 2022

    “Finally, I Can Do Something About It Myself”: A Process Evaluation of the Plants for Joints Lifestyle Intervention

    Carlijn Wagenaar1, Alie Toonstra1, Wendy Walrabenstein1, Dirkjan van Schaardenburg2 and Femke van Nassau2, 1Reade Rheumatology Center, Amsterdam, Netherlands, 2Amsterdam UMC, Amsterdam, Netherlands

    Background/Purpose: Plants for Joints (PFJ) is a multidisciplinary intervention centered around a whole-food plant-based diet, physical activity, and sleep and stress management.1 The PFJ intervention…
  • Abstract Number: 1348 • ACR Convergence 2022

    We Asked Patients and Families: What Is the Job of a Pediatric Rheumatologist?

    Emily Hause1, Nathan Rubin2, Bryce Binstadt1, Colleen Correll1, Patricia Hobday1, Alison Lerman1, Shawn Mahmud1, Mona Riskalla1, Meghan Ryan3, Zachary Shaheen1 and Danielle Bullock1, 1University of Minnesota, Minneapolis, MN, 2University of Minnesota Masonic Cancer Center, Minneapolis, MN, 3University of Minnesota, Vadnais Heights, MN

    Background/Purpose: Pediatric rheumatology is a highly specialized field, with approximately 300 practicing pediatric rheumatologists in the United States. Prior research into patient understanding of medical…
  • Abstract Number: 1344 • ACR Convergence 2022

    Patient-reported Outcomes in Lupus Low Disease Activity State: Impact of Fatigue

    Rodrigo De Moura Rodrigues, Alexandre Moura dos Santos, Daniel Sampaio Cardoso, Emily Figueiredo Neves Yuki, Danieli Castro Oliveira de Andrade, Sandra Gofinet Pasoto, Eduardo Ferreira Borba Neto, Eloisa Silva Dutra de Oliveira Bonfa and Luciana Seguro, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Patient Reported Outcomes (PROs) can be assessed by self-administered questionnaires and can lead to better decision-making by physicians. The aim of this study was…
  • Abstract Number: 1355 • ACR Convergence 2022

    Relationships Between Work Productivity, Activity Impairment, and Select Patient-Reported Outcomes in Patients with Ankylosing Spondylitis: A Post Hoc Analysis of Two Placebo-Controlled Trials

    Marina Magrey1, James Cheng-Chung WEI2, Arne Yndestad3, Andrew Bushmakin4, Joseph Cappelleri4, Oluwaseyi Dina5 and Atul Deodhar6, 1Case Western Reserve University, University Hospitals, Richfield, OH, 2Chung Shan Medical University Hospital, Taichung, Taiwan, 3Pfizer Inc, Oslo, Norway, 4Pfizer Inc, Groton, CT, 5Pfizer Inc, New York, NY, 6Oregon Health & Science University, Portland, OR, USA, Portland, OR

    Background/Purpose: Patients (pts) with AS often experience impaired work productivity.1 In pts with AS receiving tofacitinib (oral Janus kinase inhibitor), improvements were observed in work…
  • Abstract Number: 1354 • ACR Convergence 2022

    Early Real-World Effectiveness of Upadacitinib in Rheumatoid Arthritis Using Patient-Reported Outcomes Collected via Mobile Application

    Leslie Harrold1, Patrick Zueger2, William Benjamin Nowell3, Taylor Blachley1, Paul Lakin1, David Curtis4, Laura Stradford3, Shilpa Venkatachalam5, Namita Tundia2 and Pankaj Patel2, 1CorEvitas, LLC, Waltham, MA, 2AbbVie, Inc., North Chicago, IL, 3Global Healthy Living Foundation, Nyack, NY, 4Global Healthy Living Foundation, Upper Nyack, NY, 5Global Healthy Living Foundation, New York, NY

    Background/Purpose: Little is known about the impact of upadacitinib (UPA) in rheumatoid arthritis (RA) during the initial weeks of therapy in real-world clinical practice. Our…
  • Abstract Number: 1356 • ACR Convergence 2022

    Patient-perceived Disease Burden and Self-reported Medication Adherence in Systemic Autoimmune Diseases: A Monocentric Observational Study

    Camille Mettler1, Veronique Le Guern2, Paul Legendre1, Caroline Morbieu1, Tali-Anne Swebel1, Xavier Puéchal3, Pascal Cohen3, Hicham Kardaoui1, Alexandre Moores1, Luc Mouthon3, Nathalie Costedoat-Chalumeau4 and Benjamin Terrier3, 1Department of Internal Medicine, National Referral Center for Rare Systemic and Autoimmune Diseases, Cochin Hospital, Paris, France, 2Hôpital Cochin, Paris, France, 3National Referral Center for Rare Systemic Autoimmune Diseases, Cochin Hospital, Paris, France, 4Inserm DR Paris 5, Paris, France

    Background/Purpose: Systemic autoimmune diseases (AID) are chronic conditions with significant burden related to the disease itself, its management, and treatments. Burden refers to the workload…
  • Abstract Number: 1297 • ACR Convergence 2022

    A Paediatric-Adult Provider Dyad Care Model Improves Transition from Paediatric to Adult Health Care for Youth with Childhood-Onset Systemic Lupus Erythematosus

    Tala El Tal1, Abdulaziz el Mutairi1, Amanda Steiman2 and Earl Silverman3, 1The Hospital for Sick Children, Division of Rheumatology, Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 2Sinai Health System, Toronto, ON, Canada, 3The Hospital for Sick Children and University of Toronto, Toronto, ON, Canada

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic multi-system autoimmune disease affecting 1 in 1000 individuals, of whom 20% develop the disease in childhood. Childhood-onset…
  • Abstract Number: 1247 • ACR Convergence 2022

    Lung Ultrasound in Patients with Connective Tissue Disease-associated Interstitial Lung Disease; Utility of Single Evaluation in Clinical Practice

    Shinji Watanabe1, Keina Yomono2, Mikito Suzuki2, Nobuhito Sasaki2, Takahisa Gono2 and Masataka Kuwana2, 1Nippon Medical School Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan, 2Nippon Medical School Graduate School of Medicine, Tokyo, Japan

    Background/Purpose: Utility of lung ultrasound (LUS) in evaluation of interstitial lung disease (ILD) has recently attracted attention because of handiness and low invasiveness. The majority…
  • « Previous Page
  • 1
  • …
  • 570
  • 571
  • 572
  • 573
  • 574
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology